NCT07326709: A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease
- State
- Under way
- Phase
- Phase 3
- People
- 770 planned
- Started
- 24 Mar 2026
- Primary completion
- 2 Apr 2030
- Arms
- Votoplam
- Results
- None posted
- 8 Jan 2026: Trial registered
- 24 Mar 2026: Trial started